Literature DB >> 6180032

The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1.

R Zawatzky, I Gresser, E DeMaeyer, H Kirchner.   

Abstract

C57BL/6 (B6) mice are relatively resistant to infection with herpes simplex virus type 1 (HSV-1). Paradoxically, B6 mice were resistant to 250 LD50 (50% lethal dose) of HSV-1 but were killed by 25 or 2.5 LD50 of HSV-1 injected intraperitoneally. At the injection site 250 LD50 of virus induced high titers of interferon (IFN) (greater than 1,000 international units) that reached maximal levels 2-4 hr after inoculation, whereas 25 or 2.5 LD50 of HSV-1 generated only borderline levels of IFN (15-40 international units). Simultaneous inoculation of 250 LD50 of HSV-1 and antiserum to mouse IFN (MuIFN) rendered B6 mice susceptible to infection; however, treatment with antiserum to MuIFN did not increase susceptibility to 1 LD50 of virus. Injections of MuIFN given 2 hr before and 2 hr after inoculation with virus protected B6 mice against 25 LD50 of virus. Thus, endogenous IFN induced after injection with 250 LD50 of HSV-1 protects B6 mice, whereas low doses of virus kill the animals because they do not generate a detectable IFN response at the infection site.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180032     DOI: 10.1093/infdis/146.3.405

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  The Type I Interferon Response and Age-Dependent Susceptibility to Herpes Simplex Virus Infection.

Authors:  Daniel Giraldo; Douglas R Wilcox; Richard Longnecker
Journal:  DNA Cell Biol       Date:  2017-03-09       Impact factor: 3.311

2.  Assessment of hazard risk associated with the intravenous use of viral vectors in rodents.

Authors:  Jon D Reuter; Xiaoqun Fang; Christina S Ly; Karen K Suter; Daniel Gibbs
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

3.  Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.

Authors:  Francisco J Branco; Nigel W Fraser
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster.

Authors:  J De Maeyer-Guignard; F Dandoy; D W Bailey; E De Maeyer
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  The in situ cellular immune response in acute herpes simplex encephalitis.

Authors:  R A Sobel; A B Collins; R B Colvin; A K Bhan
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

6.  Therapy of genital herpes with topically applied interferon.

Authors:  L J Eron; C Toy; B Salsitz; R R Scheer; D L Wood; P I Nadler
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  Sex differences in murine susceptibility to systemic viral infections.

Authors:  Theresa L Geurs; Elaise B Hill; Danna M Lippold; Anthony R French
Journal:  J Autoimmun       Date:  2011-12-29       Impact factor: 7.094

8.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production.

Authors:  E B Pedersen; S Haahr; S C Mogensen
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.